Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma.

F M Debruyne; L Denis; G Lunglmayer; C Mahler; D W Newling; B Richards; M R Robinson; P H Smith; E H Weil; P Whelan

doi:10.1016/s0022-5347(17)41809-x

Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma.

Identifier:nobleid.org/w1/20260515/763DFB9F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/763DFB9F.svg?ark=w1%2F20260515%2F763DFB9F)](https://nobleid.org/work/w1/20260515/763DFB9F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma.

Identifier:nobleid.org/w1/20260515/763DFB9F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/763DFB9F.svg?ark=w1%2F20260515%2F763DFB9F)](https://nobleid.org/work/w1/20260515/763DFB9F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work